BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25410877)

  • 1. Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge.
    Kraatz F; Wernike K; Hechinger S; König P; Granzow H; Reimann I; Beer M
    J Virol; 2015 Feb; 89(3):1825-37. PubMed ID: 25410877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccination regimes against Schmallenberg virus infection in IFNAR
    Boshra HY; Charro D; Lorenzo G; Sánchez I; Lazaro B; Brun A; Abrescia NG
    Antiviral Res; 2017 May; 141():107-115. PubMed ID: 28235558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Schmallenberg virus prototype vaccines.
    Wernike K; Nikolin VM; Hechinger S; Hoffmann B; Beer M
    Vaccine; 2013 Aug; 31(35):3558-63. PubMed ID: 23707449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a small fragment of the Schmallenberg virus nucleoprotein highly conserved across the Orthobunyaviruses of the Simbu serogroup reduces viremia in SBV challenged IFNAR
    Guerra GS; Barriales D; Lorenzo G; Moreno S; Anguita J; Brun A; Abrescia NGA
    Vaccine; 2023 May; 41(20):3275-3284. PubMed ID: 37085455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection.
    Hechinger S; Wernike K; Beer M
    Vet Res; 2013 Dec; 44(1):114. PubMed ID: 24313924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal domain of Schmallenberg virus envelope protein Gc is highly immunogenic and can provide protection from infection.
    Wernike K; Aebischer A; Roman-Sosa G; Beer M
    Sci Rep; 2017 Feb; 7():42500. PubMed ID: 28211908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Schmallenberg virus subunit vaccine candidate protects IFNAR
    Boshra H; Lorenzo G; Charro D; Moreno S; Guerra GS; Sanchez I; Garrido JM; Geijo M; Brun A; Abrescia NGA
    Sci Rep; 2020 Nov; 10(1):18725. PubMed ID: 33230115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines.
    Endalew AD; Faburay B; Trujillo JD; Gaudreault NN; Davis AS; Shivanna V; Sunwoo SY; Ma W; Drolet BS; McVey DS; Morozov I; Wilson WC; Richt JA
    J Vet Sci; 2019 Nov; 20(6):e58. PubMed ID: 31775185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the Schmallenberg Virus Gc Glycoprotein Facilitate Cellular Protein Synthesis Shutoff and Restore Pathogenicity of NSs Deletion Mutants in Mice.
    Varela M; Pinto RM; Caporale M; Piras IM; Taggart A; Seehusen F; Hahn K; Janowicz A; de Souza WM; Baumgärtner W; Shi X; Palmarini M
    J Virol; 2016 Jun; 90(11):5440-5450. PubMed ID: 26984728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schmallenberg virus non-structural protein NSm: Intracellular distribution and role of non-hydrophobic domains.
    Kraatz F; Wernike K; Reiche S; Aebischer A; Reimann I; Beer M
    Virology; 2018 Mar; 516():46-54. PubMed ID: 29329078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schmallenberg virus-two years of experiences.
    Wernike K; Conraths F; Zanella G; Granzow H; Gache K; Schirrmeier H; Valas S; Staubach C; Marianneau P; Kraatz F; Höreth-Böntgen D; Reimann I; Zientara S; Beer M
    Prev Vet Med; 2014 Oct; 116(4):423-34. PubMed ID: 24768435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
    Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
    Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological and Serological Responses of Sheep and Cattle to Experimental Schmallenberg Virus Infection.
    Endalew AD; Morozov I; Davis AS; Gaudreault NN; Wernike K; Bawa B; Ruder MG; Drolet BS; McVey DS; Shivanna V; Ma W; Faburay B; Wilson WC; Richt JA
    Vector Borne Zoonotic Dis; 2018 Dec; 18(12):697-703. PubMed ID: 30109977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle.
    Wernike K; Mundt A; Link EK; Aebischer A; Schlotthauer F; Sutter G; Fux R; Beer M
    Vaccine; 2018 Aug; 36(34):5116-5123. PubMed ID: 30049630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies against Simbu serogroup viruses in cattle and sheep, Nigeria, 2012-2014.
    Oluwayelu D; Wernike K; Adebiyi A; Cadmus S; Beer M
    BMC Vet Res; 2018 Sep; 14(1):277. PubMed ID: 30200958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonstructural Protein NSs of Schmallenberg Virus Is Targeted to the Nucleolus and Induces Nucleolar Disorganization.
    Gouzil J; Fablet A; Lara E; Caignard G; Cochet M; Kundlacz C; Palmarini M; Varela M; Breard E; Sailleau C; Viarouge C; Coulpier M; Zientara S; Vitour D
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of inactivated trivalent vaccine for the teratogenic Aino, Akabane and Chuzan viruses.
    Kim YH; Kweon CH; Tark DS; Lim SI; Yang DK; Hyun BH; Song JY; Hur W; Park SC
    Biologicals; 2011 May; 39(3):152-7. PubMed ID: 21411335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High genetic variability of Schmallenberg virus M-segment leads to efficient immune escape from neutralizing antibodies.
    Wernike K; Reimann I; Banyard AC; Kraatz F; La Rocca SA; Hoffmann B; McGowan S; Hechinger S; Choudhury B; Aebischer A; Steinbach F; Beer M
    PLoS Pathog; 2021 Jan; 17(1):e1009247. PubMed ID: 33497419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a recombinant Akabane mutant virus with knockout of a nonstructural protein NSs in a pregnant goat model.
    Takenaka-Uema A; Bangphoomi N; Shioda C; Uchida K; Gen F; Kato K; Haga T; Murakami S; Akashi H; Hoimoto T
    Virol Sin; 2016 Jun; 31(3):274-7. PubMed ID: 27068656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.